Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

XTL Biopharmaceuticals (XTLB) Earnings Date, Estimates & Call Transcripts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Earnings Summary

Upcoming
Earnings Date
Aug. 8Estimated
Actual EPS
(May. 13)
$0.10 Beat By $0.10
Skip Charts & View Estimated and Actual Earnings Data

XTLB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

XTLB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

XTLB Earnings Date and Information

XTL Biopharmaceuticals last announced its earnings data on May 13th, 2024. The biopharmaceutical company reported $0.10 earnings per share for the quarter. XTL Biopharmaceuticals has generated $0.00 earnings per share over the last year. XTL Biopharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.

XTL Biopharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/8/2024
(Estimated)
------- 
5/13/2024Q1 2024-$0.10+$0.10$0.10--
11/15/2023Q3 2023-($0.04)($0.04)($0.04)--
8/10/2023Q2 2023-($0.07)($0.07)($0.07)--
5/16/2023Q1 2023-($0.17)($0.17)($0.17)--
3/22/2023Q4 2022-($0.14)($0.14)($0.14)--
11/29/2022Q3 2022-($0.15)($0.15)($0.15)--
Kiss of death from Joe Biden (Ad)

In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election…

To get all the details, go here now.
8/24/2022Q2 2022-($0.10)($0.10)($0.10)--
3/30/2022Q4 2021-$0.40+$0.40$0.40--
11/24/2021Q3 2021-($0.10)($0.10)($0.10)--
8/24/2021Q2 2021-($0.22)($0.22)($0.22)--
5/19/2021Q1 2021-$0.05+$0.05$0.05--
3/15/2021Q4 2020-$0.04+$0.04$0.04--
8/24/2020Q2 2020-($0.08)($0.08)($0.08)--
3/12/2020Q4 2019-($0.30)($0.30)($0.30)--
11/27/2019Q3 2019-($0.24)($0.24)($0.24)--
9/4/2019Q2 2019-($0.56)($0.56)($0.56)--

XTL Biopharmaceuticals Earnings - Frequently Asked Questions

When is XTL Biopharmaceuticals's earnings date?

XTL Biopharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on XTLB's earnings history.

How much profit does XTL Biopharmaceuticals generate each year?

XTL Biopharmaceuticals (NASDAQ:XTLB) has a recorded net income of -$1.78 million. XTLB has generated $0.00 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:XTLB) was last updated on 5/31/2024 by MarketBeat.com Staff

From Our Partners